Calidi Biotherapeutics, Inc., a biotechnology company specializing in biological products, has increased its stock offering capacity under its existing Sales Agreement with Ladenburg Thalmann & Co.
The company's India business, comprising both formulations and consumer wellness divisions, contributed 38 per cent of ...